Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Regenxbio Inc (RGNX)

27.4 0.3 (1.11%)

01-22 16:00

Open:

27.6

Pre. Close:

27.1

High:

28.05

Low:

26.8

Volume:

570,560

Market Cap:

853M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

28.09 - 28.247

28.247 - 28.391

Low:

26.392 - 26.594

26.594 - 26.779

Close:

27.105 - 27.4

27.4 - 27.67

Technical analysis  (as of: 2018-01-22 4:26:15 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 37.68     One year: 42.57

Support:

Support1: 25.48    Support2: 21.20

Resistance:

Resistance1: 32.26    Resistance2: 36.45

Pivot:

29.72

Moving Averages:

MA(5): 27.52     MA(20): 30.68

MA(100): 29.35     MA(250): 23.41

MACD:

MACD(12,26): -0.81     Signal(12,26,9): -0.32

%K %D:

%K(14,3): 17.08     %D(3): 18.65

RSI:

RSI(14): 42.75

52-Week:

High: 36.45  Low: 16.3  Change(%): 39.1

Average Vol(K):

3-Month: 39229  10-Days 56041

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
RGNX has closed above bottom band by 32.1%. Bollinger Bands are 90.4% wider than normal. The large width of the bands suggest high volatility as compared to RGNX's normal range. The bands have been in this wide range for 17 bars. This is a sign that the current trend might continue.

Headline News

Thu, 04 Jan 2018 21:00:00 GMT
REGENXBIO Provides Year-End 2017 Corporate Update

Mon, 08 Jan 2018 12:56:15 GMT
REGENXBIO and AveXis Announce Expansion of Relationship through Amended ...

Tue, 16 Jan 2018 22:30:00 GMT
REGENXBIO Inc. (RGNX) Plunges 9.03% on January 16

Fri, 05 Jan 2018 22:30:08 GMT
REGENXBIO Inc. (RGNX) Moves Lower on Volume Spike for January 05

Thu, 11 Jan 2018 22:30:00 GMT
REGENXBIO Inc. (RGNX) Soars 6.79% on January 11

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

31.15

Shares Float (M)

30.88

% Held by Insiders

% Held by Institutions

61.80

Shares Short (K)

1296

Shares Short Prior Month (K)

1010

Stock Financials

EPS

-2.700

EPS Est. Current Year

-2.930

EPS Est. Next Year

-2.950

EPS Est. Next Quarter

-0.770

Forward EPS

-3.080

Book Value (p.s.)

4.340

PEG Ratio

1.43

Profit Margin

Operating Margin

-793.67

Return on Assets (ttm)

-37.1

Return on Equity (ttm)

-40.1

Qtrly Rev. Growth

968.8

Gross Profit (p.s.)

0.245

Sales Per Share

EBITDA (p.s.)

-2.427

Qtrly Earnings Growth

Operating Cash Flow (M)

-64.59

Levered Free Cash Flow (M)

-48.92

atoplab.com

Valuation

P/E

-10.15

P/E Growth Ratio

0.01

P/BV

6.31

P/S

2438599936.00

P/CF

-13.21

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.